Cargando…

Artemisinin-naphthoquine combination versus chloroquine-primaquine to treat vivax malaria: an open-label randomized and non-inferiority trial in Yunnan Province, China

BACKGROUND: Plasmodium vivax is the main malaria parasite in China, and China is now making efforts to eliminate malaria by 2020. Radical cure of vivax malaria is one of challenges for malaria elimination. The purpose is to evaluate the efficacy and safety of artemisinin-naphthoquine (ANQ) versus ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hui, Yang, Heng-lin, Xu, Jian-Wei, Wang, Jia-zhi, Nie, Ren-hua, Li, Chun-fu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833846/ https://www.ncbi.nlm.nih.gov/pubmed/24215565 http://dx.doi.org/10.1186/1475-2875-12-409

Ejemplares similares

Efficacy and safety of artemisinin-based combination therapy and chloroquine with concomitant primaquine to treat Plasmodium vivax malaria in Brazil: an open label randomized clinical trial
por: Daher, André, et al.
Publicado: (2018)

Artemisinin‐naphthoquine for treating uncomplicated Plasmodium falciparum malaria
por: Isba, Rachel, et al.
Publicado: (2015)

Chloroquine–Primaquine versus Chloroquine Alone to Treat Vivax Malaria in Afghanistan: An Open Randomized Superiority Trial
por: Awab, Ghulam Rahim, et al.
Publicado: (2017)

Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria
por: Chu, Cindy S, et al.
Publicado: (2018)

Artemisinin-Naphthoquine versus Artemether-Lumefantrine for Uncomplicated Malaria in Papua New Guinean Children: An Open-Label Randomized Trial
por: Laman, Moses, et al.
Publicado: (2014)

Therapeutic efficacy of chloroquine and primaquine for Plasmodium vivax malaria treatment in southeast Iran
por: Heidari, Aliehsan, et al.
Publicado: (2012)

Absence of gender influence on the pharmacokinetics of chloroquine combined with primaquine in malaria vivax patients
por: Vieira, Michelle Valeria Dias Ferreira, et al.
Publicado: (2020)

The effect of SNPs in CYP450 in chloroquine/primaquine Plasmodium vivax malaria treatment
por: Sortica, Vinicius A, et al.
Publicado: (2016)

Artemisinin-Naphthoquine Combination (ARCO(®)): An Overview of the Progress
por: Hombhanje, Francis W., et al.
Publicado: (2010)

Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
por: Daher, André, et al.
Publicado: (2019)

Open-label trial of three dosage regimens of fixed-dose combination of artemisinin and naphthoquine for treating uncomplicated falciparum malaria in calabar, Nigeria
por: Meremikwu, Martin M, et al.
Publicado: (2012)

Characteristics of molecular markers associated with chloroquine resistance in Plasmodium vivax strains from vivax malaria cases in Yunnan Province, China
por: Ding, Hongyun, et al.
Publicado: (2023)

Monitoring Plasmodium vivax chloroquine sensitivity along China-Myanmar border of Yunnan Province, China during 2008–2013
por: Liu, Hui, et al.
Publicado: (2014)

A systematic review of the efficacy of a single dose artemisinin–naphthoquine in treating uncomplicated malaria
por: Naing, Cho, et al.
Publicado: (2015)

Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial
por: Smithuis, Frank, et al.
Publicado: (2010)

Failure of Supervised Chloroquine and Primaquine Regimen for the Treatment of Plasmodium vivax in the Peruvian Amazon
por: Graf, Paul C. F., et al.
Publicado: (2012)

Cost-effectiveness of artemisinin–naphthoquine versus artemether–lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children
por: Moore, Brioni R., et al.
Publicado: (2017)

Where chloroquine still works: the genetic make-up and susceptibility of Plasmodium vivax to chloroquine plus primaquine in Bhutan
por: Wangchuk, Sonam, et al.
Publicado: (2016)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial
por: Awab, Ghulam Rahim, et al.
Publicado: (2010)

Primaquine in vivax malaria: an update and review on management issues
por: Fernando, Deepika, et al.
Publicado: (2011)

Plasmodium vivax Malaria Relapses after Primaquine Prophylaxis
por: Reddy, Pavani, et al.
Publicado: (2006)

Molecular surveillance of chloroquine resistance in Plasmodium vivax isolates from malaria cases in Yunnan Province of China using pvcrt-o gene polymorphisms
por: Ding, Hongyun, et al.
Publicado: (2023)

Population Pharmacokinetics of Antimalarial Naphthoquine in Combination with Artemisinin in Tanzanian Children and Adults: Dose Optimization
por: Ali, Ali Mohamed, et al.
Publicado: (2022)

The Efficacy of Artesunate, Chloroquine, Doxycycline, Primaquine and a Combination of Artesunate and Primaquine against Avian Malaria in Broilers
por: SOHSUEBNGARM, Damnern, et al.
Publicado: (2014)

Pharmacogene Variation in Thai Plasmodium vivax Relapse Patients Treated with a Combination of Primaquine and Chloroquine
por: Chamnanphon, Monpat, et al.
Publicado: (2020)

Efficacy and safety of artemisinin-naphthoquine versus dihydroartemisinin-piperaquine in adult patients with uncomplicated malaria: a multi-centre study in Indonesia
por: Tjitra, Emiliana, et al.
Publicado: (2012)

Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
por: Llanos-Cuentas, A., et al.
Publicado: (2019)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
por: Setyadi, Agus, et al.
Publicado: (2019)

Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria
por: Watson, James A., et al.
Publicado: (2022)

Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India
por: Saravu, Kavitha, et al.
Publicado: (2016)

Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria
por: Chu, Cindy S, et al.
Publicado: (2019)

Impact of climate variability on Plasmodium vivax and Plasmodium falciparum malaria in Yunnan Province, China
por: Bi, Yan, et al.
Publicado: (2013)

Pharmacokinetic Interactions between Primaquine and Chloroquine
por: Pukrittayakamee, Sasithon, et al.
Publicado: (2014)

Pharmacokinetics of chloroquine and primaquine in healthy volunteers
por: Daher, André, et al.
Publicado: (2022)

Artemisinin-naphthoquine combination (ARCO™) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: A preliminary report on safety and efficacy
por: Hombhanje, Francis W, et al.
Publicado: (2009)

Efficacy of Artesunate-mefloquine for Chloroquine-resistant Plasmodium vivax Malaria in Malaysia: An Open-label, Randomized, Controlled Trial
por: Grigg, Matthew J., et al.
Publicado: (2016)

Therapeutic assessment of chloroquine–primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India
por: Rishikesh, Kumar, et al.
Publicado: (2015)

An Observational Study Comparing the Effects of Chloroquine and Artemisinin-Based Combination Therapy on Hematological Recovery in Patients With Plasmodium vivax Malaria
por: Rao, Sharada Shri, et al.
Publicado: (2023)

Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam
por: Phong, Nguyen Chinh, et al.
Publicado: (2019)

Primaquine plus artemisinin combination therapy for reduction of malaria transmission: promise and risk
por: John, Chandy C.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_akvaa1hvjekop6t66ragsq1shb